Xgeva (denosumab), To Protect Bones Of Patients With Advanced Cancer Approved By FDA
 

Patients with cancer that has metastasized (spread) may benefit from treatment with Xgeva (denosumab), which has been approved by the FDA (Food and Drug Administration) today. Specifically, Xgeva is designed to protect against skeletal-related events in advanced cancer patients who have bone damage - bone metastasis...

More...